FEMY
Price
$0.35
Change
+$0.01 (+2.94%)
Updated
Sep 26, 01:07 PM (EDT)
Capitalization
11.24M
41 days until earnings call
GH
Price
$59.44
Change
-$0.74 (-1.23%)
Updated
Sep 26, 01:10 PM (EDT)
Capitalization
7.5B
34 days until earnings call
Interact to see
Advertisement

FEMY vs GH

Header iconFEMY vs GH Comparison
Open Charts FEMY vs GHBanner chart's image
Femasys
Price$0.35
Change+$0.01 (+2.94%)
Volume$100
Capitalization11.24M
Guardant Health
Price$59.44
Change-$0.74 (-1.23%)
Volume$7K
Capitalization7.5B
FEMY vs GH Comparison Chart in %
Loading...
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FEMY vs. GH commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEMY is a StrongBuy and GH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (FEMY: $0.34 vs. GH: $60.18)
Brand notoriety: FEMY: Not notable vs. GH: Notable
FEMY represents the Pharmaceuticals: Other, while GH is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FEMY: 97% vs. GH: 161%
Market capitalization -- FEMY: $11.24M vs. GH: $7.5B
FEMY [@Pharmaceuticals: Other] is valued at $11.24M. GH’s [@Medical Specialties] market capitalization is $7.5B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B. The average market capitalization across the [@Medical Specialties] industry is $10.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FEMY’s FA Score shows that 0 FA rating(s) are green whileGH’s FA Score has 0 green FA rating(s).

  • FEMY’s FA Score: 0 green, 5 red.
  • GH’s FA Score: 0 green, 5 red.
According to our system of comparison, GH is a better buy in the long-term than FEMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FEMY’s TA Score shows that 4 TA indicator(s) are bullish while GH’s TA Score has 4 bullish TA indicator(s).

  • FEMY’s TA Score: 4 bullish, 3 bearish.
  • GH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FEMY is a better buy in the short-term than GH.

Price Growth

FEMY (@Pharmaceuticals: Other) experienced а -4.11% price change this week, while GH (@Medical Specialties) price change was +2.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.55%. For the same industry, the average monthly price growth was -3.61%, and the average quarterly price growth was +8.32%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.94%. For the same industry, the average monthly price growth was +3.13%, and the average quarterly price growth was +25.24%.

Reported Earning Dates

FEMY is expected to report earnings on Nov 06, 2025.

GH is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (-0.94% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($7.51B) has a higher market cap than FEMY($11.2M). GH YTD gains are higher at: 96.989 vs. FEMY (-68.636). FEMY has higher annual earnings (EBITDA): -18.34M vs. GH (-368.35M). GH has more cash in the bank: 629M vs. FEMY (3.22M). FEMY has less debt than GH: FEMY (7.85M) vs GH (1.33B). GH has higher revenues than FEMY: GH (829M) vs FEMY (1.89M).
FEMYGHFEMY / GH
Capitalization11.2M7.51B0%
EBITDA-18.34M-368.35M5%
Gain YTD-68.63696.989-71%
P/E RatioN/AN/A-
Revenue1.89M829M0%
Total Cash3.22M629M1%
Total Debt7.85M1.33B1%
FUNDAMENTALS RATINGS
GH: Fundamental Ratings
GH
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FEMYGH
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPEV22.250.98
+4.61%
XPeng
MYRG192.883.48
+1.84%
MYR Group
ASYS8.97-0.07
-0.77%
Amtech Systems
KRNT14.03-0.47
-3.24%
Kornit Digital Ltd
POAI0.95-0.23
-19.47%
Predictive Oncology

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with NTRA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
+4.35%
NTRA - GH
57%
Loosely correlated
-0.15%
VCYT - GH
56%
Loosely correlated
+0.43%
TWST - GH
48%
Loosely correlated
-1.00%
RGEN - GH
42%
Loosely correlated
-2.27%
GKOS - GH
40%
Loosely correlated
-1.59%
More